The company offers professional products to its customers in different regions. Zcosmo is an international UK aesthetic supplier delivering high-quality cosmetic products as well as future plans for adding unique
• Primary air-insulated, metal-clad switchgear with acclaimed vacuum EvoPacT circuit breakers offer best-in-class technology for large and complex medium voltage (MV) power distribution and control • New digital features integrated
The InnoVision Awards organization expanded its board of directors to increase representation from around the state. Elected this year for two-year terms; Kella Player Hanna, Program Manager, Academic Innovations at
Super Purposes offers the How to Get a Job in 12 Weeks course, tailor-made for LGBTQ+ folks! Super Purposes™ celebrates Pride 2022 with a one-of-a-kind online course made by and
In this era of extremely serious environmental protection issues, Haier Biomedical is mindful of global environmental protection concerns and has taken the initiative and corporate social responsibility for a large
(Reporter: JUDY) With the development of the world’s national economy and the continuous enhancement of the comprehensive national strength of all countries, the construction industry, as the foundation of national
Winning Recognition in the U.S. Market with Innovation & Technology, Haier Biomedical Continues to Demonstrate Its International Capability. With the new variant emerging in several countries around the world, new
SINGAPORE – May 24, 2022 – ArchLoot is a recently launched UGC-P2E game that provides highly interactive gameplay that is powered by on-chain implementation of upgradeable characters and props NFTs.
Alvio respiratory device to be manufactured by ADMT Tronics (OTCQB-ADMT) being launched via crowdfunding campaign on Indiegogo. Northvale, NJ – QoL Devices Inc., www.qoldevices.com, announced today that it has launched
Developing Multiple Unique Cannabinoid & Psychedelic Medicine Therapies Targeted for U.S. FDA Approval and Registration. Completed Loyalty Option Program to Raise A$23.6M Primarily Allocated to Clinical R&D Program. Plans Underway
